ATE264855T1 - 4-(aminoalkoxy)benzofurane als n- myristoyltransferasehemmer - Google Patents

4-(aminoalkoxy)benzofurane als n- myristoyltransferasehemmer

Info

Publication number
ATE264855T1
ATE264855T1 AT99968791T AT99968791T ATE264855T1 AT E264855 T1 ATE264855 T1 AT E264855T1 AT 99968791 T AT99968791 T AT 99968791T AT 99968791 T AT99968791 T AT 99968791T AT E264855 T1 ATE264855 T1 AT E264855T1
Authority
AT
Austria
Prior art keywords
benzofuranes
aminoalkoxy
transferase inhibitors
myristoyl transferase
myristoyl
Prior art date
Application number
AT99968791T
Other languages
English (en)
Inventor
Yuhko Aoki
Hirosato Ebiike
Toshihiko Fujii
Kenichi Kawasaki
Pingli Liu
Miyako Masubuchi
Tatsuo Ohtsuka
Shinji Tsujii
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Application granted granted Critical
Publication of ATE264855T1 publication Critical patent/ATE264855T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D307/85Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Furan Compounds (AREA)
AT99968791T 1998-12-18 1999-12-10 4-(aminoalkoxy)benzofurane als n- myristoyltransferasehemmer ATE264855T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98124120 1998-12-18
PCT/EP1999/009763 WO2000037464A2 (en) 1998-12-18 1999-12-10 4-(aminoalkoxy)benzofurans as n-myristoyltransferase inhibitors

Publications (1)

Publication Number Publication Date
ATE264855T1 true ATE264855T1 (de) 2004-05-15

Family

ID=8233179

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99968791T ATE264855T1 (de) 1998-12-18 1999-12-10 4-(aminoalkoxy)benzofurane als n- myristoyltransferasehemmer

Country Status (18)

Country Link
US (1) US6376491B1 (de)
EP (1) EP1149094B1 (de)
JP (1) JP3435404B2 (de)
KR (1) KR20010081117A (de)
CN (1) CN1333770A (de)
AR (1) AR021714A1 (de)
AT (1) ATE264855T1 (de)
AU (1) AU754233B2 (de)
BR (1) BR9916318A (de)
CA (1) CA2355694A1 (de)
DE (1) DE69916664T2 (de)
DK (1) DK1149094T3 (de)
ES (1) ES2217882T3 (de)
MX (1) MXPA01006218A (de)
PE (1) PE20001324A1 (de)
TR (1) TR200101779T2 (de)
WO (1) WO2000037464A2 (de)
ZA (1) ZA200104410B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ516111A (en) * 1999-05-24 2003-05-30 Mitsubishi Pharma Corp Phenoxypropylamine compounds useful to treat depression
SE9902987D0 (sv) * 1999-08-24 1999-08-24 Astra Pharma Prod Novel compounds
JP4042566B2 (ja) * 2000-11-27 2008-02-06 田辺三菱製薬株式会社 ピペリジン化合物およびその医薬用途
US7078541B2 (en) * 2002-02-07 2006-07-18 Galileo Pharmaceuticals, Inc. Benzofuran derivatives
US6653346B1 (en) * 2002-02-07 2003-11-25 Galileo Pharmaceuticals, Inc. Cytoprotective benzofuran derivatives
WO2006015279A1 (en) * 2004-07-28 2006-02-09 Neurogen Corporation Heterocyclic diamine compounds as ligands of the melanin concentrating hormone receptor useful for the treatment of obesity, diabetes, eating and sexual disorders
JPWO2007020936A1 (ja) * 2005-08-17 2009-02-26 第一三共株式会社 抗真菌作用二環性複素環化合物
US20090270496A1 (en) * 2007-05-03 2009-10-29 Courchesne William E Antifungal compounds
GB0815947D0 (en) * 2008-09-02 2008-10-08 Univ Dundee Compounds
AU2009304596A1 (en) 2008-10-17 2010-04-22 Akaal Pharma Pty Ltd S1P receptors modulators
CN102186845B (zh) 2008-10-17 2016-09-07 阿卡制药有限公司 S1p受体调节剂以及它们的用途
GB201120993D0 (en) 2011-12-06 2012-01-18 Imp Innovations Ltd Novel compounds and their use in therapy
GB201511382D0 (en) 2015-06-29 2015-08-12 Imp Innovations Ltd Novel compounds and their use in therapy
CN107540725B (zh) * 2016-06-29 2020-04-07 孙青� 一种水溶性丹参酮ⅱa衍生物及其制备与应用
GB201820660D0 (en) 2018-12-19 2019-01-30 Imperial Innovations Ltd Cancer treatments
GB201820659D0 (en) 2018-12-19 2019-01-30 Imperial Innovations Ltd Novel compostions and their use in therapy
GB202014736D0 (en) 2020-09-18 2020-11-04 Imperial College Innovations Ltd Novel compounds and their use in therapy
GB202017367D0 (en) 2020-11-02 2020-12-16 Imperial College Innovations Ltd Novel use
WO2024052685A1 (en) 2022-09-09 2024-03-14 MyricX Pharma Limited Cytotoxic imidazo[1,2-a]pyridine compounds and their use in therapy

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1129072A (en) * 1966-02-01 1968-10-02 Ici Ltd Benzofuran and indole derivatives
GB1256735A (de) * 1969-03-06 1971-12-15
US4056626A (en) 1971-05-13 1977-11-01 Kakenyaku Kako Co., Ltd. Pharmaceutical composition containing benzofuran derivative
CA989411A (en) * 1971-05-13 1976-05-18 Kakenyaku Kako Co. Benzofuran derivatives and preparation thereof
CA1089866A (en) * 1975-10-20 1980-11-18 Kiyoshi Ito Benzofuran derivatives, preparation thereof and pharmaceutical compositions thereof
SU671256A1 (ru) * 1977-06-08 1986-11-23 Всесоюзный Научно-Исследовательский Химико-Фармацевтический Институт Им.С.Орджоникидзе Гидрохлорид 1-(2-карбэтокси-3-метилбензофуран-4-илокси-3-изопропиламино)-2-пропанола,обладающий антиаритмическим и @ -адреноблокирующим действием
JPS5740479A (en) * 1980-08-21 1982-03-06 Kaken Pharmaceut Co Ltd Preparation of benzofuran derivative and its acid addition salt
EP0146243A1 (de) * 1983-10-31 1985-06-26 Merck Frosst Canada Inc. Lipoxygenase-Inhibitoren
US5082967A (en) * 1988-06-16 1992-01-21 Washington University Novel fatty acid analog enzyme substrates
FR2672598A1 (fr) * 1991-02-11 1992-08-14 Adir Nouveaux inhibiteurs de n-myristoyltransferase, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
JPH07215940A (ja) * 1994-01-27 1995-08-15 Torii Yakuhin Kk 抗ウイルス活性を有する化合物
JPH08198826A (ja) * 1995-01-23 1996-08-06 Torii Yakuhin Kk 抗ウイルス活性を有する化合物

Also Published As

Publication number Publication date
TR200101779T2 (tr) 2001-12-21
KR20010081117A (ko) 2001-08-27
DE69916664T2 (de) 2005-03-31
PE20001324A1 (es) 2000-12-02
BR9916318A (pt) 2001-08-14
DK1149094T3 (da) 2004-08-16
AU754233B2 (en) 2002-11-07
AU2660600A (en) 2000-07-12
US6376491B1 (en) 2002-04-23
JP3435404B2 (ja) 2003-08-11
ES2217882T3 (es) 2004-11-01
EP1149094B1 (de) 2004-04-21
WO2000037464A3 (en) 2000-11-02
CN1333770A (zh) 2002-01-30
CA2355694A1 (en) 2000-06-29
MXPA01006218A (es) 2002-04-17
JP2002533340A (ja) 2002-10-08
WO2000037464A2 (en) 2000-06-29
EP1149094A2 (de) 2001-10-31
AR021714A1 (es) 2002-07-31
ZA200104410B (en) 2002-08-29
DE69916664D1 (de) 2004-05-27

Similar Documents

Publication Publication Date Title
ATE264855T1 (de) 4-(aminoalkoxy)benzofurane als n- myristoyltransferasehemmer
ATE437862T1 (de) Pyrimidin-5-onderivate als ldl-pla2 inhibitoren
ATE370137T1 (de) 4-(6-gliedriger)-heteroaryl-acyl-pyrrolidin derivate als hcv-inhibitoren
NO20023705D0 (no) Bestemmelse av art/type for et underjordisk reservoar
NO20011883D0 (no) System for adgangskontroll
NO20024130D0 (no) Sirkulasjonssystem for brönnhull
NO20012474L (no) Styresystem for dyptsatte brönnventiler
DE69906311D1 (de) Diarylbenzopyranderivate als cyclooxygenase-2-inhibitoren
ATE416170T1 (de) Substituierte 2-phenyl benzofurane als oestrogenwirksame substanzen
ATE428420T1 (de) Substituierte 8-arylchinoline als phosphodiesterase-4-hemmer
DE59806475D1 (de) Urokinase-inhibitoren
NO20032315D0 (no) 4-(bifenylkarbonylamino)piperidinderivater som MTP- inhibitorer
DE60105195D1 (de) Benzofuran- und benzothiophen-derivative als selektive cox-2 inhibitoren
ATE320418T1 (de) Substituierte benzo(b)azepin-2-on-verbindungen als schmerzmittel
DK1217002T3 (da) 2-(4-pyridinyl)benzofuraner som metalloproteaseinhibitorer
NO20025474L (no) Benzofuranderivater
ATE323673T1 (de) Pyrrolidin-2-carbonsäure-hydrazid-derivate als metalloprotease-inhibitoren
DE50007501D1 (de) Benzofuranderivate
ATA1092002A (de) Pflug
DE60106606D1 (de) Substituierte stilbenverbindungen als glucoseaufnahme inhibitoren
DE69904814D1 (de) Isoquinoline als urokinase inhibitoren
DE60225958D1 (de) Pflug
NO20005683D0 (no) Ny formulering inneholdende paroxetin
DE60139781D1 (de) 4-substituierte piperidinverbindung
EE200300386A (et) Võrguliides juurdepääsuks objektidele või nende juhtimiseks

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1149094

Country of ref document: EP

REN Ceased due to non-payment of the annual fee